Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001802768-25-000101

EVP, Research & Investments acquired 2,772 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Urist Marshall EVP, Research & Investments 2025-08-06 Grant or award +2,772 39,256 D
Derivatives
Urist Marshall EVP, Research & Investments 2025-08-08 Gift · LP interests in RPI US Partners 2019, LP −3,000 263,412 I
Loading xslF345X05/wk-form4_1754686370.xml…